nausea
Medications
Instructed in new medication Allopuriniol and in S/E such as drowsiness, fever, headache, paresthesia, peripheral neuropathy, neuritis, hypersensitivity vasculitis, necrotizing angiitis, epistaxis, nausea, vomiting, diarrhea, abdominal pain, gastritis, taste loss (or perversion, dyspepsia), renal failure, uremia, agranulocytosis, anemia, aplastic anemia, thrombocytopenia, leukopenia, leukocytosis, eosinophilia, hepatitis, hepatic necrosis, hepatomegaly, cholestatic jaundice, arthralgia, myopathy, rash, exfoliative, urticarial, and purpuric lesions, erythema multiforme, severe furunculosis of nose, ichthyosis, alopecia, toxic epidermal necrolysis, ecchymoses, chills.
Instructed in new medication Cozaar and in S/E such as dizziness, asthenia, fatigue, headache, insomnia, edema, chest pain, nasal congestion, sinusitis, pharyngitis, sinus disorder, abdominal pain, nausea, diarrhea, dyspepsia, muscle cramps, myalgia, back or leg pain, cough, upper respiratory infection, angioedema, asthenia, fatigue, fever, hypesthesia, chest pain, hypotension, orthostatic hypotension, sinusitis, cataract, diarrhea, dyspepsia, gastritis, urinary tract infection, anemia, hyperkalemia, hypoglycemia, weight gain, back pain, leg or knee pain, muscle weakness, cough, bronchitis, cellulites and others.
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Advair diskus to manage asthma. In addition, warned of possible S/E such as sleep disorders, tremor, hypnagogic effects, compressed nerve syndromes, headache, pain, palpitations, pharyngitis, sinusitis, hoarseness (or dysphonia), rhinorrhea, rhinitis, sneezing, nasal irritation, blood in nasal mucosa, keratitis, conjunctivitis, eye redness, viral eye infections, congestion, nausea, vomiting, abdominal pain and discomfort, diarrhea, gastroenteritis, oral discomfort and pain, constipation, oral ulcerations, oral erythema and rashes, oral candidiasis, appendicitis, dental discomfort and pain, unusual taste, muscular pain, arthralgia, articular rheumatism, muscle stiffness, tightness, rigidity, bone and cartilage disorders, upper respiratory tract infection, upper respiratory tract inflammation, lower respiratory tract viral infection, bronchitis, cough, pneumonia, urticaria, flakiness, disorders of sweat and sebum, sweating, hives, viral infections, chest symptoms, fluid retention, bacterial infections, allergic reactions.
Instructed in new medication Prednisone and in S/E such as euphoria, insomnia, psychotic behavior, vertigo, headache, paresthesia, seizures, pseudotumor cerebri, heart failure, hypertension, edema, arrhythmias, thrombophlebitis, thromboembolism, cataracts, glaucoma, peptic ulceration, GI irritation, increased appetite, pancreatitis, nausea, vomiting, menstrual irregularities, increased urine calcium levels, hypokalemia, hyperglycemia, carbohydrate intolerance, growth suppression in children, muscle weakness, osteoporosis, hirsutism, delayed wound healing, acne and various skin eruptions.
Instructed in new medication Augmentin to manage infection. In addition, warned of possible S/E such as nausea, vomiting, headache, dizziness, skin rash, blurred vision, confusion, anxiety, redness, etc.
Instructed in new medication Allegra to manage allergic rhinitis. In addition, warned of possible S/E such as fatigue, drowsiness, nausea, dyspepsia, dysmenorrhea, and viral infection.
Instructed in new medication Feroso to manage anemia. In addition, warned of possible S/E such as nausea, vomiting, constipation, GI discomfort, headache, dizziness, dry mouth, rash and others.
Instructed in new medication Protonix to manage esophagitis. In addition, warned of possible S/E such as headache, insomnia, asthenia, dizziness, chest pain, pharyngitis, rhinitis, sinusitis, diarrhea, flatulence, abdominal pain, eructation, constipation, nausea, vomiting, urinary frequency, hyperglycemia, back pain, neck pain, hypertonia, rash, bronchitis, increased cough, etc. The drug can be taken without regard to meal.
Instructed in new medication Wellbutrin to manage depression. In addition, warned of possible S/E such as headache, seizures, anxiety, confusion, delusions, euphoria, hostility, impaired sleep quality, insomnia, sedation, tremor, akinesia, akathisia, agitation, dizziness, fatigue, syncope, fever, arrhythmias, hypertension, hypotension, palpitations, tachycardia, auditory disturbances, blurred vision, dry mouth, taste disturbance, increased appetite, constipation, dyspepsia, nausea, vomiting, anorexia, diarrhea, impotence, menstrual complaints, urinary frequency, urine retention, weight loss, weight gain, arthritis, pruritus, rash, cutaneous temperature disturbance, excessive diaphoresis, chills and decreased libido. Advised to avoid prolonged sun exposure and to use sun block.